| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.44 | 0.0004 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.49 | 0.005 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |